ADHD in Children and Adolescents: Barriers to Ethical and Successful Treatment  

作　　者：Katherine T. Smith Katherine T. Smith(School of Health Professions, Texas Tech University Health Sciences Center, Lubbock, TX, USA)

机构地区：[1]School of Health Professions, Texas Tech University Health Sciences Center, Lubbock, TX, USA

出　　处：《Journal of Biosciences and Medicines》2023年第3期58-63,共6页生物科学与医学（英文）

摘　　要：This review provides a comprehensive analysis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder characterized by inattention, hyperactivity, or impulsivity. The global prevalence of the disorder ranges from 2% to 7%, with an average of around 5%. ADHD affects individuals of all ages, with symptoms typically becoming visible as early as 3 years. The symptoms range from mild to severe and may persist into adulthood. The disorder affects a variety of demographic groups, including differences in age, gender, race, and ethnicity, with varying effects, prevalence, and treatment options among these groups. Treatment options for ADHD range from behavioral interventions to prescription medication, with a number of medications available on the market for treating ADHD. The review also highlights the issues of relapse and safety concerns associated with the use of medication, as well as the challenges associated with diversity and socioeconomic barriers in the diagnosis and treatment of the disorder.This review provides a comprehensive analysis of attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder characterized by inattention, hyperactivity, or impulsivity. The global prevalence of the disorder ranges from 2% to 7%, with an average of around 5%. ADHD affects individuals of all ages, with symptoms typically becoming visible as early as 3 years. The symptoms range from mild to severe and may persist into adulthood. The disorder affects a variety of demographic groups, including differences in age, gender, race, and ethnicity, with varying effects, prevalence, and treatment options among these groups. Treatment options for ADHD range from behavioral interventions to prescription medication, with a number of medications available on the market for treating ADHD. The review also highlights the issues of relapse and safety concerns associated with the use of medication, as well as the challenges associated with diversity and socioeconomic barriers in the diagnosis and treatment of the disorder.

关 键 词：ADHD Neurodevelopmental Disorder Medication Safety SOCIOECONOMIC Attention Deficit Hyperactivity Disorder 

分 类 号：R74[医药卫生—神经病学与精神病学]